Skip to content

The effect of ultrasound-guided subcostal quadratus lumborum block on perioperative analgesia in retroperitoneal laparoscopic renal surgery

The effect of ultrasound-guided subcostal quadratus lumborum block on perioperative analgesia in retroperitoneal laparoscopic renal surgery

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000030647
Enrollment
Unknown
Registered
2020-03-08
Start date
2020-03-01
Completion date
Unknown
Last updated
2020-03-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Retroperitoneal laparoscopic kidney surgery

Interventions

Group 1: Quadratus Lumborum Block

Sponsors

Chifeng Municipal Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1) patients undergoing retroperitoneal laparoscopic single kidney surgery under elective general anesthesia, who are expected to receive PCA pump (the drug in the pump is oxycodone) after surgery; (2) for patients undergoing endotracheal intubation under static inhalation combined with general anesthesia, ASA grades from I to II; (3) aged from 18 to 65 years; (4) body mass index (BMI): 18-24 kg/m2; (5) participate in the clinical trial voluntarily and sign the informed consent.

Exclusion criteria

Exclusion criteria: (1) analgesic drugs and alcohol were used 24 h before surgery; (2) refuse to participate in the study and cannot cooperate with the operation; (3) patients with severe hypertension, heart disease, diabetes or severe liver and kidney dysfunction before surgery; (4) local anaesthetic allergy; (5) puncture contraindication, including skin damage, infection or coagulation dysfunction at the puncture site; (6) pregnant or nursing women; (7) participate in other clinical trials within 3 months prior to study inclusion.

Design outcomes

Primary

MeasureTime frame
Total dose of oxycodone for 48 hours;

Secondary

MeasureTime frame
Opioid dosage during surgery;At 2 h, 6 h, 12 h, 24 h, 36 h, and 48 h after surgery, NRS score of resting and NRS score of exercise was obtained;Remedial treatment occurred within 48 h after surgery;Safety evaluation (occurrence of hypoemia, hypomyosis, nausea and vomiting, respiratory depression, drowsiness, etc. within 48 hours after operation);

Contacts

Public ContactJiannan Song

Department of Anesthesiology, Chifeng Municipal Hospital

18847600734@163.com+86 15049683795

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026